Registered entities
Voyager Therapeutics, Inc.
Reg. No. 1640266United States
VOYAGER THERAPEUTICS INC
Reg. No. 463003182United States
Innovation
143 patent families (30 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 50,843 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 15 |
| 2018 | 16 |
| 2019 | 34 |
| 2020 | 44 |
| 2021 | 50 |
| 2022 | 40 |
| 2023 | 39 |
| 2024 | 61 |
| 2025 | 61 |
| 2026 | 18 |
Social engagement
Social engagement: 44.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; lead investors include Brookside Capital, PFM Health Sciences; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 40% |
| Private equity | 3 | 30% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 2 | 20% |
Hiring activity
Hires occasionally
2 roles tracked across 2 of the last 12 months
12 Jan 2026 · Quality Assurance Specialist · Cambridge
7 Feb 2025 · Executive Assistant to Chief Financial Officer (C- Level) · Cambridge
Based on job postings tracked across public sources.
Recent activity
29 Jun 2026
Event
AAIC26 poster presentation on good laboratory practice (GLP) toxicology data for VY1706
1 Jun 2026
Milestone
regulatory